Austin J, Hockey D, Williams WR, Hutchison S. Assessing parenteral diuretic treatment of decompensated heart failure in the community. Brit J Community Nurs. 2013; 18:(11)528-534

Barton A. Shifting intravenous therapy from hospital to the patient's home. Brit J Community Nurs. 2018; 23:(4)170-172

Brightpurpose. Evaluation of IV diuretics pilot for the British Heart Foundation. Final Report. 2014. (accessed 9 November 2021)

British Heart Foundation. A new at-home treatment for heart failure. 2012. (accessed 9 November 2021)

Dougherty L. Intravenous therapy in older patients. Nurs Standard. 2013; 28:(6)50-58

‘A bleak picture’: nurse vacancies increase across English NHS. 2021. (accessed 14 November 2021)

King's Fund. Key facts and figures about the NHS. 2019. (accessed 9 November 2021)

King's Fund. NHS hospital bed numbers: past, present, future. 2021. (accessed 9 November 2021)

National Institute for Cardiovascular Outcomes Research. National heart failure audit: April 2015–March 2016. 2017. (accessed 9 November 2021)

National Institute for Health and Care Excellence. Furosemide. 2021. (accessed 9 November 2021)

Passmore J. Complexities of symptom management in heart failure. Brit J Cardiac Nurs. 2016; 11:(11)558-563

Payne D. Administering intravenous therapy in patients' homes. Brit J Community Nurs. 2019; 24:(2)67-71

Quinn M, Read H. Nurse-led community diuretics for heart failure patients. Brit J Cardiac Nurs. 2014; 9:(1)31-38

Sankaranarayanan R, Kanagala P, Douglas H, Rawat A, Hassan S, Beleznai T, Lee C. Ambulatory management of acute decompensation in heart failure. Brit J Hosp Med. 2019; 80:(1)40-45

University Hospitals Birmingham. FOI 0778 Tariff/Cost of Bed. 2019. (accessed 9 November 2021)

Veilleux RP, Wight JN, Cannon A, Whalen M, Bachman D. Home diuretic protocol for heart failure: partnering with home health to improve outcomes and reduce readmissions. Perm J. 2014; 18:(3)44-48

Management of patients with chronic heart failure in the community. Primary Health Care. 2014; 24:(9)35-41

Intravenous diuretic administration in the home environment

02 December 2021
10 min read
Volume 26 · Issue 12


Chronic heart failure is a condition associated with ageing, affecting 1–2% of the adult population, raising to 70% of the adult population over 70 years of age. Diuretics are often the first-line treatment for patients with symptomatic heart failure, not just oedema. Traditionally, intravenous (IV) diuretic therapy has been administered only in hospitals. In 2012, the British Heart Foundation ran a pilot study investigating the effectiveness of IV diuretic administration within the home. Since then, there has been an increase in these services. This article examines the advantages and disadvantages of this service, whether community nurses are best placed to deliver this, and what the benefits to the patient might be.

In 2012, the British Heart Foundation (BHF) announced a pilot study to evaluate giving IV diuretics in the patient's home. It claimed that it would end weeks of hospital in-patient care for people with severe heart failure and could be rolled out across the UK if successful (BHF, 2012). We are now beginning to see this being provided for patients in the community, but it is not without its challenges.

For more than a decade, the Department of Health and Social Care has championed a policy of moving services from the hospital environment into the community setting, closer to where patients live (Barton, 2018). In 2017, the National Institute for Cardiovascular Outcomes Research (NICOR) called for improved and earlier detection and management of oedema in the community, to prevent the need for hospital admission (NICOR, 2017). Providing IV diuretics in the home environment meets both of these objectives, but there are far more benefits to this than mere compliance with these two polices.

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month